| Annual Financials | 2025 | 2026 | TTM |
Revenue  | 77 | 138 | 0 |
| Expenses | 51 | 87 | 0 |
| EBITDA | 26 | 52 | 0 |
| Operating Profit % | 33 % | 37 % | 0 % |
| Depreciation | 1 | 1 | 0 |
| Interest | 3 | 4 | 0 |
| Profit Before Tax | 22 | 47 | 0 |
| Tax | 6 | 13 | 0 |
| Net Profit | 17 | 34 | 0 |
| EPS in ₹ | 14.11 | 20.77 | 0.00 |
Anondita Medicare
Anondita Medicare
1,078.70
-5.90
(-0.54%)
Market Cap
2,054.36 Cr
PE Ratio
60.22
Volume
1,16,200.00
Day High - Low
1,096.00 - 1,040.15
52W High-Low
1,316.00 - 335.00
Key Fundamentals
Market Cap
2,054.36 Cr
EPS
20.77
PE Ratio
60.22
PB Ratio
9.38
Book Value
115.66
EBITDA
51.50
Dividend Yield
0.00 %
Industry
Consumer Goods Sector
Personal Care Return on Equity
26.13
Debt to Equity
0.37
Actual
Company News
View All News
Confirmed supply order from Central Medical Services Society under India's Family Planning Programme. Q1FY27 order inflow stood at Rs 105.47 crore across 6 orders; FY26 revenue grew 78.2% YoY to Rs 137.42 crore.
Anondita Medicare allots warrants to promoters
Jul 11, 2026
Jul 11, 2026Anondita Medicare allotted 2,85,000 warrants to promoters at ₹1,038 each, aggregating ₹29.58 crore. The warrants are convertible into equity shares within 18 months.
Anondita Medicare to host investor meetJul 09, 2026
Jul 09, 2026Anondita Medicare Limited will hold an in-person meeting with investors in Mumbai on July 11, 2026. The discussion will rely on publicly available information.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
840.00 | #1 85,957.62 | 45.67 | #1 15,444.10 | 7.90 | 1,862 | 11.49 | 29.05 | |
374.25 | 66,390.34 | 34.73 | 13,792.30 | 5.18 | #1 1,869 | 15.33 | 35.11 | |
1,735.00 | 47,189.51 | 35.80 | 6,124.20 | -0.89 | 1,325 | 7.02 | 31.81 | |
312.50 | 42,020.65 | 305.49 | 391.40 | #1 92.62 | 108 | #1 194.67 | 67.01 | |
6,899.00 | 22,480.54 | 34.14 | 3,127.40 | 38.21 | 654 | 9.40 | 31.35 | |
6,639.00 | 21,550.68 | 27.92 | 4,332.90 | 27.00 | 857 | -34.25 | 10.17 | |
372.65 | 16,266.17 | #1 22.08 | 3,864.60 | -0.33 | 775 | -15.46 | 42.72 | |
427.90 | 13,950.58 | 56.32 | 2,475.50 | 15.37 | 200 | 118.89 | 33.76 | |
497.05 | 6,492.38 | 29.02 | 1,191.80 | 19.13 | 190 | 84.86 | 47.06 | |
1,078.70 | #10 2,054.36 | #9 60.22 | #10 138.30 | #2 79.38 | #10 34 | - | 45.93 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
79.38 %
Net Income Growth
107.88 %
Cash Flow Change
243.78 %
ROE
-39.40 %
ROCE
-35.47 %
EBITDA Margin (Avg.)
11.42 %
Yearly Financial Results
Order Value Trend
FY 2026-27 order value₹104.49 Cr
QoQ growth-91.69%
FY 2026-279 Orders
Supra Healthcare Johannesburg ...
41.29%Supra Healthcare Johannesburg ...
41.29%Central Medical Services Socie...
9.67%Central Medical Services Socie...
7.67%Lotus Pharmaceuticals Pvt Ltd
0.05%Others
0.04%Balance Sheet
| Balance Sheet | 2025 | 2026 |
| Total Assets | 77 | 185 |
| Fixed Assets | 13 | 39 |
| Current Assets | 54 | 99 |
| Capital Work in Progress | 7 | 42 |
| Investments | 0 | 0 |
| Other Assets | 58 | 104 |
| Total Equity & Liabilities | 77 | 185 |
| Current Liabilities | 27 | 28 |
| Non Current Liabilities | 12 | 26 |
| Total Equity | 38 | 131 |
| Reserve & Surplus | 24 | 111 |
| Share Capital | 13 | 18 |
Cash Flow
| Cash Flow | 2025 | 2026 |
| Net Cash Flow | 0 | 9 |
| Investing Activities | -19 | -63 |
| Operating Activities | -7 | 11 |
| Financing Activities | 26 | 61 |
Share Holding
| % Holding | Dec 2024 | Aug 2025 | Sept 2025 | Mar 2026 |
| Promoter | 83.95 % | 61.71 % | 61.79 % | 62.40 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 3.40 % |
| DIIs | 0.00 % | 0.65 % | 0.00 % | 5.70 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 21.42 % | 17.13 % | 18.84 % |
| Others | 16.05 % | 16.22 % | 21.08 % | 9.65 % |
| No of Share Holders | 57 | 86 | 621 | 530 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 13 Nov 2025 |  Quarterly Result Announcement | NA | 13 Nov 2025 | 600.20 | 605.00 |
| 12 Feb 2026 |  Extraordinary General Meeting | NA | 12 Feb 2026 | 952.85 | 825.10 |
| 22 May 2026 | Quarterly Result Announcement | NA | 22 May 2026 | 929.65 | 1,066.15 |
| 28 May 2026 | Extraordinary General Meeting | NA | 28 May 2026 | 1,020.30 | 1,013.25 |
| 02 Sept 2026 |  Rights | 97:1831 | 02 Sept 2026 | 1,075.50 | 1,051.95 |
Technical Indicators
RSI(14)
Neutral 45.93
ATR(14)
Less Volatile 56.40
STOCH(9,6)
Neutral 41.91
STOCH RSI(14)
Oversold 5.45
MACD(12,26)
Bearish -4.80
ADX(14)
Weak Trend 16.90
UO(9)
Bearish 49.99
ROC(12)
Downtrend And Accelerating -5.45
WillR(14)
Neutral -73.15
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
